surgery seminar 2014

Upload: caisham

Post on 04-Jun-2018

221 views

Category:

Documents


0 download

TRANSCRIPT

  • 8/13/2019 Surgery Seminar 2014

    1/76

    SEMINAR HEPATO BILLARYSURGERY

    BY, Kadhiravan

    ThayabalaCaisha

  • 8/13/2019 Surgery Seminar 2014

    2/76

    PORTAL HYPERTENSION

    S. Kadhiravan

  • 8/13/2019 Surgery Seminar 2014

    3/76

    Hepatic portal circulation carries blood from GI tract (i.e.from the distal esophagus to anorectal junction) to the liver.

    Portal venous blood drain into liver venous sinusoids andhence in to the hepatic veins.

    Introduction

  • 8/13/2019 Surgery Seminar 2014

    4/76

  • 8/13/2019 Surgery Seminar 2014

    5/76

  • 8/13/2019 Surgery Seminar 2014

    6/76

    Portal hypertension develop when there is elevation of portalpressure is greater than 12 mmHg, while normal portal

    pressure is 5

    10mmHg.

    Decrease or reverse portal blood flow to the liver promotethe development/formation of portal-systemic collaterals,

    shunting of portal blood flow to systemic circulationbypassing the liver

    PortalHypertension

  • 8/13/2019 Surgery Seminar 2014

    7/76

    Portosystemic anastomosis occurs in junctional areas ofvenous drainage.

    The main sites of the collaterals are at the gastro-oesophageal junction,

    the rectum,

    the left renal vein,

    the diaphragm,

    the retroperitoneum

    anterior abdominal wall via the umbilical vein.

  • 8/13/2019 Surgery Seminar 2014

    8/76

    Child Pug Classification Of PortalHypertension

  • 8/13/2019 Surgery Seminar 2014

    9/76

    Pre Hepatic:

    1- Congenital portal atresia

    2- Portal vein thrombosis (Neonatal sepsis)

    3- Phlebitis of portal vein (abdominal infection)

    4- Trauma or thrombosed porto caval shunt.

    Hepatic:

    1- Cirrhosis (alcoholic most frequently)

    2- Chronic Active hepatitis

    3- Parasitic diseases (Schiatosomiasis)

    Causes Of Portal Hypertension

  • 8/13/2019 Surgery Seminar 2014

    10/76

    Post Hepatic:

    1- Budd Chiari syndrome (Hepatic venous thrombosis)

    2- Constrictive pericarditis3- Tricuspid valve incompetence

  • 8/13/2019 Surgery Seminar 2014

    11/76

    Surgical Implications

    Upper GI bleed from oesophageal varices

    Ascites due to liver cell dysfunction

    Congestive splenomegaly

  • 8/13/2019 Surgery Seminar 2014

    12/76

  • 8/13/2019 Surgery Seminar 2014

    13/76

    Physical Examination

    General examination

    Level of consciousness

    Vital parameters

    Signs of hepatocellular failure :-

    Ascites, Jaundice, Gynaecomastia, Spider angiomas, Palmer

    erythema, Asterixis, Foetor hepaticus.

  • 8/13/2019 Surgery Seminar 2014

    14/76

  • 8/13/2019 Surgery Seminar 2014

    15/76

    Investigation

    Laboratory

    Cbc

    Lft

    Coagulation profile

    Hepatitis markers (HbsAg)

    Serum levels of BUN,creatinine,electrolytes

    Blood grouping and cross matching

  • 8/13/2019 Surgery Seminar 2014

    16/76

    Investigation

    Endoscopy

    Oesophageal varices

    Blood clot over the varix

    Varix over varix

    Cherry red spots

    Salmon patches

    Fundic varices

    Gastritis

    Chronic duodenal ulcer

  • 8/13/2019 Surgery Seminar 2014

    17/76

    Investigation

    Radiology

    USG - Status of liver

    Status of spleen

    Free fluid Portal cavernoma

    Duplex doppler

    Venous phase of superior mesenteric angiogram

    Barium oesophagogram

    Splenoportogram

    Barium oesophagogram

    CT CSAN

  • 8/13/2019 Surgery Seminar 2014

    18/76

    General resuscitation

    Anti coagulation for Budd Chiari syndrome

    Treatment of hepatic cause

    Treatment Of Chronic Complication such as Esophageal gastric varices:

    1- Beta blocker (propranolol or nadolol), reduce portal venouspressure.

    2- Repeated injection sclerotherapy or variceal ligation

    3- Elective porto

    systemic shunt (spleno

    renal anastomosis)4- Liver transplant may be considered for treatment if associated with

    severe liver diseases.

    Treatment

  • 8/13/2019 Surgery Seminar 2014

    19/76

    Acute Variceal Bleeding

  • 8/13/2019 Surgery Seminar 2014

    20/76

    Initial Evaluation & Stabilization

    1. Assessment of intravascular volume status

    2. Fluid resuscitation

    3. Endotracheal intubation prior to endoscopy for:

    Uncontrolled bleeding

    Altered mental status, severe agitation

    Respiratory distress or depression

  • 8/13/2019 Surgery Seminar 2014

    21/76

    Pharmacologic

    Radiologic shuntTIPSS

    Surgical Shunt

    Balloon

    Tamponade

    Pharmacologic andendoscopic therapy

    are the usual 1stand2ndinterventions

    Endoscopic

    Treatment forAcute Variceal Bleeding

  • 8/13/2019 Surgery Seminar 2014

    22/76

    1. Octreotide

    Synthetic analogue of somatostatin

    Decreases portal pressure and azygos blood flow

    Stops variceal bleed in 80% of the cases

    Efficacy is similar to endoscopic sclerotherapy and betterthan vasopressin

    Pharmacologic Therapy

  • 8/13/2019 Surgery Seminar 2014

    23/76

    2. Vasopressin

    Reduces portal pressure but causes myocardial andmesenteric ischemia (more side effects)

    Control approximately 50% of acute episodes

  • 8/13/2019 Surgery Seminar 2014

    24/76

    3. Terlipressin

    Efficacy similar to endoscopic sclerotherapy and as effectiveas balloon tamponade when used with nitroglycerin

  • 8/13/2019 Surgery Seminar 2014

    25/76

    Endoscopic Therapy

    Sclerosant injection

    Band ligation

    Became a standard form of therapy in acute varicealbleeding

    Initial control of hge in 70 95%

    Re-bleeding 20 50%

  • 8/13/2019 Surgery Seminar 2014

    26/76

    5% sodium morrhuate

    5% ethanolamine oleate

    Intravariceally : to obliterate the varix

    Paravariceally : induce submucus fibrosis

    Sclerotherapy achieved better initial hge control

    Fewer episodes of rebleeding Improved long-term survival

    Sclerotherapy

  • 8/13/2019 Surgery Seminar 2014

    27/76

    Alternative to sclerotherapy

    Fewer rebleeding episodes

    Fewer endoscopic interventions

    Lower procedure related mortality and over all mortality

    Band Ligation

  • 8/13/2019 Surgery Seminar 2014

    28/76

  • 8/13/2019 Surgery Seminar 2014

    29/76

    Balloon positioning

  • 8/13/2019 Surgery Seminar 2014

    30/76

    Direct temponade therapy is 90% effective in controllingthe bleeding

    50% rebleeding after removal

    Serious potential complications (mortality 20%)

  • 8/13/2019 Surgery Seminar 2014

    31/76

    Creating an intrahepatic portosystemic fistula todecompress the portal hypertension

    First performed in 1982

    (non- selective side to side portosystemic shunt)

    Transjagular IntrahepaticPortosystemic Shunting (TIPS)

  • 8/13/2019 Surgery Seminar 2014

    32/76

    1. Cannulating the Rt hepatic vein via internal jagular vein

    2. Passing needle through liver parenchyma to portal vein branch

    3. Guide wire

    4. Balloon dilatation

  • 8/13/2019 Surgery Seminar 2014

    33/76

    5stenting the tract

  • 8/13/2019 Surgery Seminar 2014

    34/76

  • 8/13/2019 Surgery Seminar 2014

    35/76

    1. Contraindications:

    R side heart failure

    Polycystic liver

    Portal vein thrombosis

    2. Complication

    Intraperitoneal bleeding due to perforation of the hepaticcapsule, hepatic, or portal veins

    TIPS embolization

    Acute right heart failure due to increased venous return to rightheart

  • 8/13/2019 Surgery Seminar 2014

    36/76

    Most effective method in controlling portal hypertension and recurrent

    bleeding

    1 Portosystemic shunt procedures

    2 Esophagogastric devascularization

    3 Orthotopic liver transplantation

    Surgical Therapy

  • 8/13/2019 Surgery Seminar 2014

    37/76

    1Non selective Shunts

    1. End to side portocaval (Eck'sfistula):

    Higher rate of encephalopathyamong operative shunting

    groups

    Better control of rebleeding thanmedical treatment

    Eck fistula medical therapy same incidence of

    encephalopathy

  • 8/13/2019 Surgery Seminar 2014

    38/76

    2. Side to Side portocavalshunt:

    Maintain the anatomiccontinuity of the portal vein

    Encephalopathy rate : nodifference

    Decompress the sinusoidalpressure better ascitis

    control

    Recommended for BuddChiari Syndrome

    More difficult than end toside

  • 8/13/2019 Surgery Seminar 2014

    39/76

    . Interpositionesocaval Shunt:

    Prosthetic autogennous vien

    Avoid hilar dissection(future transplant)

    Shunt ligation inrefractory post-op

    encephalopathy

    Drawback thrombosis(35%)

  • 8/13/2019 Surgery Seminar 2014

    40/76

    4. Proximal Spleno-Renal Shunt:

    Splenectomy +

    anastomosing proximalSplenic vein to Lt Renalvein

    Divert all portal flowinto renal vein non

    selective

    Shunt occlusion 18%

  • 8/13/2019 Surgery Seminar 2014

    41/76

  • 8/13/2019 Surgery Seminar 2014

    42/76

    Coronary

    Caval Shunt:

    Described in Japan in1984

    Interposition graftbetween L Gastricand inferior vena cava

  • 8/13/2019 Surgery Seminar 2014

    43/76

    Esophagogastric Devascularization

    The most effectivenon-shunt operationfor preventing varicealbleeding:

    Devascularization+ transection +splenectomy

    Sugiura procedure

    O th t i Li

  • 8/13/2019 Surgery Seminar 2014

    44/76

    Orthotopic LiverTransplantation

    The most definitive form oftherapy for complications of portalhypertension

    Selective patients:

    CoastUnavailability

    Immunosuppresion

  • 8/13/2019 Surgery Seminar 2014

    45/76

    Understanding the natural history of portal hypertension PH and due to other etiologies may have significant

    implications in choosing the appropriate interventionand predicting the outcome.

    Conclusion

  • 8/13/2019 Surgery Seminar 2014

    46/76

    ACS Surgery : Principles and Practice 2004 Web,MD

    Schwartz Principles of Surgery 7thEdition

    Johns Hopkins Gastroenterology & Hepatology ResourceCenter (http://hopkins-gi.nts.jhu.edu)

    References

  • 8/13/2019 Surgery Seminar 2014

    47/76

    CHOLEDOLITHIASIS

  • 8/13/2019 Surgery Seminar 2014

    48/76

    ACUTE CHOLECYSTITIS

  • 8/13/2019 Surgery Seminar 2014

    49/76

    ACUTE CHOLECYSTITISETIOLOGY:

    Mostly associated withCholelithiasis.

    In 95% gall stone is foundimpacted In cystic duct.

  • 8/13/2019 Surgery Seminar 2014

    50/76

    Types of Gall stones:

    1) Mixed stones commonest

    2) Pure cholesterol stones

    3) Pigment stones

    black & brown

  • 8/13/2019 Surgery Seminar 2014

    51/76

    Common organisms grown are:

    E.Coli , Klebsiella & Streptococcus fecalis.

    Rarely Bacteroides & Clostridia may be

    found (gas seen in gall bladder).

    Acute Cholecystitis may occur as a

    complication of Typhoid & perforation can

    occur.

  • 8/13/2019 Surgery Seminar 2014

    52/76

    Pathophysiology:

    (1) cystic duct obstruction with GBdistension & ischemia,

    (2) Mechanical (stone) injury to mucosa

    (3) bacterial infection.

  • 8/13/2019 Surgery Seminar 2014

    53/76

    Gall stones (by causing obstruction

    to bile flow & GB distension) &lysolecithin in bile which damages

    the mucosa play a part in the

    pathology.Added to this is secondary

    bacterial infection.

  • 8/13/2019 Surgery Seminar 2014

    54/76

  • 8/13/2019 Surgery Seminar 2014

    55/76

    Perforation of gall bladder- usually

    occurs in fundus (due to ischemia) orat neck (due to pressure necrosis).

    It may form a localised abscess or

    diffuse peritonitis (mortality rate 50%).

  • 8/13/2019 Surgery Seminar 2014

    56/76

    Clinical features:

    Sudden onsetPain in hypochondrium

    Nausea & vomiting

    Pyrexia >38oC

    Neutrophilia

    Tenderness & guarding in hypochondrium

  • 8/13/2019 Surgery Seminar 2014

    57/76

    Sometimes a mass may be

    felt. Boasssign- an area of

    hyperesthesia between 9th&

    11thribs posteriorly on the

    side.

    Murphys sign- holdingbreath on hypochondrial

    palpation.

  • 8/13/2019 Surgery Seminar 2014

    58/76

    Signs of sepsis, shock &generalised peritonitis may

    be present in elderly patients

    or in a case of perforation.

  • 8/13/2019 Surgery Seminar 2014

    59/76

    Diagnosis:Plain X-ray chest & abdomen

    Ultrasonography

    Radionuclide cholescintigraphyusing Tc99m isotope scan

    ERCP or PTC if other tests do not

    reveal the diagnosis.

  • 8/13/2019 Surgery Seminar 2014

    60/76

    PLAIN XRAY OF ABDOMEN

    Plain abdominal radiograph in a49-year-old diabetic womanshows air within the gallbladder

    lumen due to emphysematouscholecystitis (arrow).

  • 8/13/2019 Surgery Seminar 2014

    61/76

  • 8/13/2019 Surgery Seminar 2014

    62/76

  • 8/13/2019 Surgery Seminar 2014

    63/76

  • 8/13/2019 Surgery Seminar 2014

    64/76

    Treatment:

    Initially conservative followed byCholecystectomy.

    Nil by mouth, naso-gastric aspiration,

    analgesics & antibiotic cover will tide over the

    crisis.

  • 8/13/2019 Surgery Seminar 2014

    65/76

    Cholecystectomy performed 2-3 days after acute

    phase subsides.

    If the patient does not improve or perforation issuspected then emergency laparotomy is

    performed.

    Cholecystostomy is done in debilitated cases.

  • 8/13/2019 Surgery Seminar 2014

    66/76

  • 8/13/2019 Surgery Seminar 2014

    67/76

    Dissection of Cystic duct

  • 8/13/2019 Surgery Seminar 2014

    68/76

    Clips applied to Cystic duct

  • 8/13/2019 Surgery Seminar 2014

    69/76

  • 8/13/2019 Surgery Seminar 2014

    70/76

    Cystic artery being dissected

  • 8/13/2019 Surgery Seminar 2014

    71/76

    Gall bladder dissected from liver

    bed

    http://localhost/var/www/apps/conversion/tmp/Downloads/Laparoscopic%20Cholecystectomy.mp4
  • 8/13/2019 Surgery Seminar 2014

    72/76

  • 8/13/2019 Surgery Seminar 2014

    73/76

    Q2. Prophylactic cholecystectomy isnot recommended for

    a) Heart transplant receipients

    b) Diabetes Mellitus c) Incidental gallstones on laparotomy

  • 8/13/2019 Surgery Seminar 2014

    74/76

    Q3. Which of the following is not anultrasonic finding in acute cholecystitis

    a) Absence of gallstomes

    b) Gallbladder wall thickness morethan 6 mm

    c) Pericholecystic fluid

    d) Sonographic Murphy's sign

  • 8/13/2019 Surgery Seminar 2014

    75/76

    Q4. Which of the following is not apremalignant condition of gallbladder?

    a) Porcelain gallbladder

    b) Adenomyomatosis of gallbladder c) Salmonella infection

    d) Phrygian cap

    Q5 Which of the following is not true regarding

  • 8/13/2019 Surgery Seminar 2014

    76/76

    Q5. Which of the following is not true regardinggallbladder cancer following cholecystectomy

    a) Subsequent treatment depends on many

    factors including stage of disease, surgicalmargins, spillage etc

    b) For T1 and T2 lesions cholecystectomy issufficient

    c) The term extended cholecystectomy ispreferred to radical cholecystectomy

    d) Common Bile Duct (CBD) excision is notrequired in all cases